Epidemiologic pattern of cancers in Iran; current knowledge and future perspective

go back to reference Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet. 2019;393(10184):1984–2005. https://doi.org/10.1016/S0140-6736(18)33197-0.CrossRefPubMed Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, et al. Iran in transition. Lancet. 2019;393(10184):1984–2005. https://​doi.​org/​10.​1016/​S0140-6736(18)33197-0.CrossRefPubMed

go back to reference Kolahdouzan S, Sajadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6. Kolahdouzan S, Sajadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6.

go back to reference Griffith A. The importance of clinical registries. J Public Health (Bangkok). 2018;41(3):648. https://doi.org/10.1093/pubmed/fdy179.CrossRef Griffith A. The importance of clinical registries. J Public Health (Bangkok). 2018;41(3):648. https://​doi.​org/​10.​1093/​pubmed/​fdy179.CrossRef

go back to reference Modirian M, Rahimzadeh S, Cheraghi Z, et al. Quality evaluation of national cancer registry system in Iran: study protocol. Arch Iran Med. 2014;17(3):193–7 https://www.sid.ir/en/journal/ViewPaper.aspx?id=364505.PubMed Modirian M, Rahimzadeh S, Cheraghi Z, et al. Quality evaluation of national cancer registry system in Iran: study protocol. Arch Iran Med. 2014;17(3):193–7 https://​www.​sid.​ir/​en/​journal/​ViewPaper.​aspx?​id=​364505.PubMed

go back to reference Salimzadeh H, Ardeshir LF, Abedian S, et al. The trend of national and sub-national burden of gastrointestinal and liver diseases in iran 1990 to 2013, Study Protocol. 2014. Salimzadeh H, Ardeshir LF, Abedian S, et al. The trend of national and sub-national burden of gastrointestinal and liver diseases in iran 1990 to 2013, Study Protocol. 2014.

go back to reference Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A, et al. National and subnational patterns of cause of death in Iran 1990–2015: applied methods. Arch Iran Med. 2017;20(1):2–11. Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A, et al. National and subnational patterns of cause of death in Iran 1990–2015: applied methods. Arch Iran Med. 2017;20(1):2–11.

go back to reference Farzadfar F, Delavari A, Malekzadeh R, et al. NASBOD 2013: design, definitions, and metrics. Arch Iran Med. 2014;17(1). Farzadfar F, Delavari A, Malekzadeh R, et al. NASBOD 2013: design, definitions, and metrics. Arch Iran Med. 2014;17(1).

go back to reference Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, 2016. Available from http://vizhub.healthdata.org/gbd-compare. Accessed Aug 2019. Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, 2016. Available from http://​vizhub.​healthdata.​org/​gbd-compare. Accessed Aug 2019.

go back to reference Rezaei N, Pishgar F, Yoosefi M, et al. National and sub-national pediatric cancer mortality in Iran, 2000–2015. Arch Iran Med. 2019;22(6). Rezaei N, Pishgar F, Yoosefi M, et al. National and sub-national pediatric cancer mortality in Iran, 2000–2015. Arch Iran Med. 2019;22(6).

go back to reference Pourshams A, Sepanlou SG, Ikuta KS, Bisignano C, Safiri S, Roshandel G, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934–47.CrossRef Pourshams A, Sepanlou SG, Ikuta KS, Bisignano C, Safiri S, Roshandel G, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934–47.CrossRef

go back to reference Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–59.CrossRef Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–59.CrossRef

go back to reference Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol (Poznan, Poland). 2019;23(1):7–15. https://doi.org/10.5114/wo.2019.84112.CrossRef Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol (Poznan, Poland). 2019;23(1):7–15. https://​doi.​org/​10.​5114/​wo.​2019.​84112.CrossRef

go back to reference Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15:997. https://doi.org/10.1186/s12889-015-2342-9.CrossRefPubMed Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15:997. https://​doi.​org/​10.​1186/​s12889-015-2342-9.CrossRefPubMed

go back to reference Ghasemian A, Ataie-Jafari A, Khatibzadeh S, Mirarefin M, Jafari L, Nejatinamini S, et al. National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990-2013; study protocol. Arch Iran Med. 2014;17(3):146–58.PubMed Ghasemian A, Ataie-Jafari A, Khatibzadeh S, Mirarefin M, Jafari L, Nejatinamini S, et al. National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990-2013; study protocol. Arch Iran Med. 2014;17(3):146–58.PubMed

go back to reference Collaboration GB of DC. Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688.CrossRef Collaboration GB of DC. Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://​doi.​org/​10.​1001/​jamaoncol.​2016.​5688.CrossRef

go back to reference Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, Ansari R, Roshandel G, Merat S, Fitzmaurice C, Force LM, Nixon MR, Abbastabar H, Abegaz KH, Afarideh M, Ahmadi A, Ahmed MB, Akinyemiju T, Alahdab F, Ali R, Alikhani M, Alipour V, Aljunid SM, Almadi MAH, Almasi-Hashiani A, al-Raddadi RM, Alvis-Guzman N, Amini S, Anber NH, Ansari-Moghaddam A, Arabloo J, Arefi Z, Asghari Jafarabadi M, Azadmehr A, Badawi A, Baheiraei N, Bärnighausen TW, Basaleem H, Behzadifar M, Behzadifar M, Belayneh YM, Berhe K, Bhattacharyya K, Biadgo B, Bijani A, Biondi A, Bjørge T, Borzì AM, Bosetti C, Bou-Orm IR, Brenner H, Briko AN, Briko NI, Carreras G, Carvalho F, Castañeda-Orjuela CA, Cerin E, Chiang PPC, Chido-Amajuoyi OG, Daryani A, Davitoiu DV, Demoz GT, Desai R, Dianati nasab M, Eftekhari A, el Sayed I, Elbarazi I, Emamian MH, Endries AY, Esmaeilzadeh F, Esteghamati A, Etemadi A, Farzadfar F, Fernandes E, Fernandes JC, Filip I, Fischer F, Foroutan M, Gad MM, Gallus S, Ghaseni-Kebria F, Ghashghaee A, Gorini G, Hafezi-Nejad N, Haj-Mirzaian A, Haj-Mirzaian A, Hasanpour-Heidari S, Hasanzadeh A, Hassanipour S, Hay SI, Hoang CL, Hostiuc M, Househ M, Ilesanmi OS, Ilic MD, Innos K, Irvani SSN, Islami F, Jaca A, Jafari Balalami N, Jafari delouei N, Jafarinia M, Jahani MA, Jakovljevic M, James SL, Javanbakht M, Jenabi E, Jha RP, Joukar F, Kasaeian A, Kassa TD, Kassaw MW, Kengne AP, Khader YS, Khaksarian M, Khalilov R, Khan EA, Khayamzadeh M, Khazaee-Pool M, Khazaei S, Khosravi Shadmani F, Khubchandani J, Kim D, Kisa A, Kisa S, Kocarnik JM, Komaki H, Kopec JA, Koyanagi A, Kuipers EJ, Kumar V, la Vecchia C, Lami FH, Lopez AD, Lopukhov PD, Lunevicius R, Majeed A, Majidinia M, Manafi A, Manafi N, Manda AL, Mansour-Ghanaei F, Mantovani LG, Mehta D, Meier T, Meles HG, Mendoza W, Mestrovic T, Miazgowski B, Miazgowski T, Mir SM, Mirzaei H, Mohammad KA, Mohammad Gholi Mezerji N, Mohammadian-Hafshejani A, Mohammadoo-Khorasani M, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Moossavi M, Moradi G, Moradpour F, Moradzadeh R, Nahvijou A, Naik G, Najafi F, Nazari J, Negoi I, Nguyen CT, Nguyen TH, Ningrum DNA, Ogbo FA, Olagunju AT, Olagunju TO, Pana A, Pereira DM, Pirestani M, Pourshams A, Poustchi H, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rahmati M, Rajati F, Rawaf DL, Rawaf S, Reiner Jr RC, Renzaho AMN, Rezaei N, Rezapour A, Saad AM, Saadatagah S, Saddik B, Salehi F, Salehi Zahabi S, Salz I, Samy AM, Sanabria J, Santric Milicevic MM, Sarveazad A, Satpathy M, Schneider IJC, Sekerija M, Shaahmadi F, Shabaninejad H, Shamsizadeh M, Sharafi Z, Sharif M, Sharifi A, Sheikhbahaei S, Shirkoohi R, Siddappa Malleshappa SK, Silva DAS, Sisay M, Smarandache CG, Soofi M, Soreide K, Soshnikov S, Starodubov VI, Subart ML, Sullman MJM, Tabarés-Seisdedos R, Taherkhani A, Tesfay B, Topor-Madry R, Traini E, Tran BX, Tran KB, Ullah I, Uthman OA, Vacante M, Vahedian-Azimi A, Valli A, Varavikova E, Vujcic IS, Westerman R, Yazdi-Feyzabadi V, Yisma E, Yu C, Zadnik V, Zahirian Moghadam T, Zaki L, Zandian H, Zhang ZJ, Murray CJL, Naghavi M, Malekzadeh R The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2019;4(12):913–933. https://doi.org/10.1016/S2468-1253(19)30345-0. Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, Ansari R, Roshandel G, Merat S, Fitzmaurice C, Force LM, Nixon MR, Abbastabar H, Abegaz KH, Afarideh M, Ahmadi A, Ahmed MB, Akinyemiju T, Alahdab F, Ali R, Alikhani M, Alipour V, Aljunid SM, Almadi MAH, Almasi-Hashiani A, al-Raddadi RM, Alvis-Guzman N, Amini S, Anber NH, Ansari-Moghaddam A, Arabloo J, Arefi Z, Asghari Jafarabadi M, Azadmehr A, Badawi A, Baheiraei N, Bärnighausen TW, Basaleem H, Behzadifar M, Behzadifar M, Belayneh YM, Berhe K, Bhattacharyya K, Biadgo B, Bijani A, Biondi A, Bjørge T, Borzì AM, Bosetti C, Bou-Orm IR, Brenner H, Briko AN, Briko NI, Carreras G, Carvalho F, Castañeda-Orjuela CA, Cerin E, Chiang PPC, Chido-Amajuoyi OG, Daryani A, Davitoiu DV, Demoz GT, Desai R, Dianati nasab M, Eftekhari A, el Sayed I, Elbarazi I, Emamian MH, Endries AY, Esmaeilzadeh F, Esteghamati A, Etemadi A, Farzadfar F, Fernandes E, Fernandes JC, Filip I, Fischer F, Foroutan M, Gad MM, Gallus S, Ghaseni-Kebria F, Ghashghaee A, Gorini G, Hafezi-Nejad N, Haj-Mirzaian A, Haj-Mirzaian A, Hasanpour-Heidari S, Hasanzadeh A, Hassanipour S, Hay SI, Hoang CL, Hostiuc M, Househ M, Ilesanmi OS, Ilic MD, Innos K, Irvani SSN, Islami F, Jaca A, Jafari Balalami N, Jafari delouei N, Jafarinia M, Jahani MA, Jakovljevic M, James SL, Javanbakht M, Jenabi E, Jha RP, Joukar F, Kasaeian A, Kassa TD, Kassaw MW, Kengne AP, Khader YS, Khaksarian M, Khalilov R, Khan EA, Khayamzadeh M, Khazaee-Pool M, Khazaei S, Khosravi Shadmani F, Khubchandani J, Kim D, Kisa A, Kisa S, Kocarnik JM, Komaki H, Kopec JA, Koyanagi A, Kuipers EJ, Kumar V, la Vecchia C, Lami FH, Lopez AD, Lopukhov PD, Lunevicius R, Majeed A, Majidinia M, Manafi A, Manafi N, Manda AL, Mansour-Ghanaei F, Mantovani LG, Mehta D, Meier T, Meles HG, Mendoza W, Mestrovic T, Miazgowski B, Miazgowski T, Mir SM, Mirzaei H, Mohammad KA, Mohammad Gholi Mezerji N, Mohammadian-Hafshejani A, Mohammadoo-Khorasani M, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Moossavi M, Moradi G, Moradpour F, Moradzadeh R, Nahvijou A, Naik G, Najafi F, Nazari J, Negoi I, Nguyen CT, Nguyen TH, Ningrum DNA, Ogbo FA, Olagunju AT, Olagunju TO, Pana A, Pereira DM, Pirestani M, Pourshams A, Poustchi H, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rahmati M, Rajati F, Rawaf DL, Rawaf S, Reiner Jr RC, Renzaho AMN, Rezaei N, Rezapour A, Saad AM, Saadatagah S, Saddik B, Salehi F, Salehi Zahabi S, Salz I, Samy AM, Sanabria J, Santric Milicevic MM, Sarveazad A, Satpathy M, Schneider IJC, Sekerija M, Shaahmadi F, Shabaninejad H, Shamsizadeh M, Sharafi Z, Sharif M, Sharifi A, Sheikhbahaei S, Shirkoohi R, Siddappa Malleshappa SK, Silva DAS, Sisay M, Smarandache CG, Soofi M, Soreide K, Soshnikov S, Starodubov VI, Subart ML, Sullman MJM, Tabarés-Seisdedos R, Taherkhani A, Tesfay B, Topor-Madry R, Traini E, Tran BX, Tran KB, Ullah I, Uthman OA, Vacante M, Vahedian-Azimi A, Valli A, Varavikova E, Vujcic IS, Westerman R, Yazdi-Feyzabadi V, Yisma E, Yu C, Zadnik V, Zahirian Moghadam T, Zaki L, Zandian H, Zhang ZJ, Murray CJL, Naghavi M, Malekzadeh R The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2019;4(12):913–933. https://​doi.​org/​10.​1016/​S2468-1253(19)30345-0.

go back to reference Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol (Poznan, Poland). 2019;23(1):7–15. https://doi.org/10.5114/wo.2019.84112.CrossRef Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol (Poznan, Poland). 2019;23(1):7–15. https://​doi.​org/​10.​5114/​wo.​2019.​84112.CrossRef

go back to reference Zayeri F, Mansouri A, Sheidaei A, et al. Evaluation of the trends of stomach cancer incidence in districts of Iran from 2000–2010: application of a random effects Markov model. Asian Pac J Cancer Prev. 2016;17(2):661–5 http://europepmc.org/abstract/MED/26925660.CrossRef Zayeri F, Mansouri A, Sheidaei A, et al. Evaluation of the trends of stomach cancer incidence in districts of Iran from 2000–2010: application of a random effects Markov model. Asian Pac J Cancer Prev. 2016;17(2):661–5 http://​europepmc.​org/​abstract/​MED/​26925660.CrossRef

go back to reference Collaboration GB of DC. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688.CrossRef Collaboration GB of DC. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://​doi.​org/​10.​1001/​jamaoncol.​2016.​5688.CrossRef

go back to reference Rezaei N, Far FF, Khademiureh S, et al. Liver cancer mortality at national and provincial levels in Iran between 1990 and 2015: a meta regression analysis. Hepat Mon. 2018;18(1). https://doi.org/10.5812/hepatmon.62009. Rezaei N, Far FF, Khademiureh S, et al. Liver cancer mortality at national and provincial levels in Iran between 1990 and 2015: a meta regression analysis. Hepat Mon. 2018;18(1). https://​doi.​org/​10.​5812/​hepatmon.​62009.

go back to reference Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–91. https://doi.org/10.1111/j.1524-4741.2007.00446.x.CrossRefPubMed Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–91. https://​doi.​org/​10.​1111/​j.​1524-4741.​2007.​00446.​x.CrossRefPubMed

go back to reference Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24–7.PubMed Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24–7.PubMed

go back to reference Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114(2):143–5. https://doi.org/10.1038/sj.ph.1900623.CrossRefPubMed Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114(2):143–5. https://​doi.​org/​10.​1038/​sj.​ph.​1900623.CrossRefPubMed

go back to reference Montazeri A, Vahdaninia M, Harirchi I, Harirchi A, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med. 2008;7(1):6. https://doi.org/10.1186/1447-056X-7-6.CrossRefPubMedPubMedCentral Montazeri A, Vahdaninia M, Harirchi I, Harirchi A, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med. 2008;7(1):6. https://​doi.​org/​10.​1186/​1447-056X-7-6.CrossRefPubMedPubMedCentral

go back to reference Esmaeimzadeh N, Salahi-Moghaddam A, Khoshdel A. Geographic distribution of important cancers in Iran. Hormozgan Med J. 2015;19(2):66–76. Esmaeimzadeh N, Salahi-Moghaddam A, Khoshdel A. Geographic distribution of important cancers in Iran. Hormozgan Med J. 2015;19(2):66–76.

go back to reference Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, et al. Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer. 2006;43(2):80–5.CrossRef Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, et al. Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer. 2006;43(2):80–5.CrossRef

go back to reference Farzadfar F, Peykari N, Larijani B, Rahimzadeh S, Rezaei-Darzi E, Saeedi MS. A comprehensive study on national and sub national trend in thyroid cancer prevalence in the iranian population, 1990–2010. Iran J Diabetes Metab. 2016;15(2):91–100. Farzadfar F, Peykari N, Larijani B, Rahimzadeh S, Rezaei-Darzi E, Saeedi MS. A comprehensive study on national and sub national trend in thyroid cancer prevalence in the iranian population, 1990–2010. Iran J Diabetes Metab. 2016;15(2):91–100.

go back to reference Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:1–10. https://doi.org/10.1155/2013/965212.CrossRef Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:1–10. https://​doi.​org/​10.​1155/​2013/​965212.CrossRef

go back to reference Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;71(3):437–46. https://doi.org/10.1016/j.eururo.2016.10.008.CrossRefPubMed Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;71(3):437–46. https://​doi.​org/​10.​1016/​j.​eururo.​2016.​10.​008.CrossRefPubMed

go back to reference Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, et al. Global, regional and national burden of bladder cancer, 1990 to 2016: results from the GBD study 2016. J Urol. 2019;201(5):893–901.CrossRef Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, et al. Global, regional and national burden of bladder cancer, 1990 to 2016: results from the GBD study 2016. J Urol. 2019;201(5):893–901.CrossRef

go back to reference Pishgar F, Haj-Mirzaian A, Ebrahimi H, Saeedi Moghaddam S, Mohajer B, Nowroozi MR, et al. Global, regional and national burden of testicular cancer, 1990-2016: results from the global burden of disease study 2016. BJU Int. 2019;124(3):386–94. https://doi.org/10.1111/bju.14771.CrossRefPubMed Pishgar F, Haj-Mirzaian A, Ebrahimi H, Saeedi Moghaddam S, Mohajer B, Nowroozi MR, et al. Global, regional and national burden of testicular cancer, 1990-2016: results from the global burden of disease study 2016. BJU Int. 2019;124(3):386–94. https://​doi.​org/​10.​1111/​bju.​14771.CrossRefPubMed

go back to reference Chesnais J-C. The demographic transition: stages, patterns, and economic implications. OUP Cat. 1992. Chesnais J-C. The demographic transition: stages, patterns, and economic implications. OUP Cat. 1992.

go back to reference Naghavi M. Transition in health status in the Islamic Republic of Iran TT -. irje. 2006;2(1):45–57. http://irje.tums.ac.ir/article-1-185-en.html. Naghavi M. Transition in health status in the Islamic Republic of Iran TT -. irje. 2006;2(1):45–57. http://​irje.​tums.​ac.​ir/​article-1-185-en.​html.

go back to reference Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3. https://doi.org/10.1186/s40200-017-0288-4.CrossRefPubMedPubMedCentral Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord. 2017;16(1):3. https://​doi.​org/​10.​1186/​s40200-017-0288-4.CrossRefPubMedPubMedCentral